Pv Nano Cell Financials
Pv Nano Cell (PVNNF) reported $479K in revenue for fiscal year 2023, down 20.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
External funding remains the dominant engine because cash burn still outweighs this business's very small sales base.
The higher FY2023 cash balance did not come from the business turning cash-generative: operating cash burn stayed near-$2.2M , and financing inflows of$2.5M were the real reason cash finished higher. With a current ratio of 0.2x, that new capital appears to be supporting near-term obligations more than building a durable liquidity cushion.
With revenue of
Negative equity narrowed from
Financial Health Signals
We are recalculating Pv Nano Cell's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Pv Nano Cell scores -15.86, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($19K) relative to total liabilities ($5.4M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Pv Nano Cell passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Pv Nano Cell reported a net loss of $2.1M while operations used $2.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Pv Nano Cell generated $479K in revenue in fiscal year 2023. This represents a decrease of 20.7% from the prior year.
Pv Nano Cell's EBITDA was -$1.9M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 58.4% from the prior year.
Pv Nano Cell reported -$2.1M in net income in fiscal year 2023. This represents an increase of 54.1% from the prior year.
Pv Nano Cell earned $0.01 per diluted share (EPS) in fiscal year 2023. This represents a decrease of 66.7% from the prior year.
Cash & Balance Sheet
Pv Nano Cell recorded an outflow of $2.2M in free cash flow in fiscal year 2023, representing a cash shortfall after capex. This represents an increase of 25.3% from the prior year.
Pv Nano Cell held $647K in cash as of fiscal year 2023; long-term debt is not reported for that period.
Not reported for fiscal year 2023.
Margins & Returns
Pv Nano Cell's gross margin was 30.7% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is down 7.0 percentage points from the prior year.
Not shown for fiscal year 2023: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for fiscal year 2023: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for fiscal year 2023.
Capital Allocation
Pv Nano Cell invested $280K in research and development in fiscal year 2023. This represents an increase of 4.4% from the prior year.
Pv Nano Cell invested $16K in capex in fiscal year 2023, funding long-term assets and infrastructure. This represents a decrease of 82.9% from the prior year.
Not reported for fiscal year 2023.
PVNNF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $479K-20.7% | $603K+6.1% | $569K-25.3% | $761K+59.1% | $479K+3.9% | $461K+419.5% | $89K+13.6% | $78K+14.3% | $68K+18.1% | $58K+97.0% | $29K |
| Cost of Revenue | $331K-11.8% | $376K+38.3% | $272K-11.7% | $308K+30.1% | $236K-39.1% | $388K+312.0% | $94K+19.9% | $79K+13.9% | $69K-12.8% | $79K+115.4% | $37K |
| Gross Profit | $147K-35.3% | $227K-23.4% | $297K+1079.4% | $25K-89.6% | $242K+234.0% | $72K+267.6% | -$43K-7892.8% | -$541+24.8% | -$719+96.6% | -$21K-188.7% | -$7K |
| R&D Expenses | $280K+4.4% | $269K-42.6% | $468K+16.7% | $401K-45.2% | $731K-5.8% | $776K+91.6% | $405K-36.0% | $633K-12.2% | $721K-24.9% | $960K+15.0% | $834K |
| SG&A Expenses | $1.4M-25.2% | $1.9M+40.7% | $1.3M-4.9% | $1.4M+7.2% | $1.3M+1.7% | $1.3M+5.7% | $1.2M+115.0% | $571K-29.3% | $807K-0.3% | $810K+132.8% | $348K |
| Operating Income | -$1.9M+61.4% | -$5.0M-96.0% | -$2.6M-194.2% | $2.7M-6.2% | $2.9M-8.6% | $3.2M+9.5% | $2.9M+288.7% | -$1.5M+13.2% | -$1.8M+7.9% | -$1.9M-48.3% | -$1.3M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $21K |
| Income Tax | $477K-54.1% | $1.0M+79.0% | $579K-79.9% | $2.9M+217.3% | $909K+100.4% | $454K-33.5% | $683K+68.4% | $405K-13.8% | $470K-18.1% | $574K+44.2% | $398K |
| Net Income | -$2.1M+54.1% | -$4.5M-79.0% | -$2.5M-120.1% | $12.5M+217.3% | $4.0M+100.4% | $2.0M-30.6% | $2.8M+275.4% | -$1.6M+8.6% | -$1.8M+55.7% | -$4.0M-151.8% | -$1.6M |
| EPS (Diluted) | $0.01-66.7% | $0.03-50.0% | $0.06 | $0.49 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
PVNNF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.4M+10.2% | $4.0M-33.3% | $6.0M-7.6% | $6.5M-7.9% | $7.1M-6.9% | $7.6M-11.5% | $8.6M+1069.3% | $737K+65.8% | $445K-57.4% | $1.0M | N/A |
| Current Assets | $1.1M+45.1% | $747K+90.2% | $393K-3.2% | $406K-6.4% | $434K-9.4% | $479K-31.9% | $703K+109.4% | $336K+48.1% | $227K-72.2% | $816K | N/A |
| Cash & Equivalents | $647K+76.0% | $368K+1366.6% | $25K-20.0% | $31K-37.7% | $50K-68.5% | $160K-65.7% | $466K+268.9% | $126K+1056.7% | $11K-98.4% | $681K+529.7% | $108K |
| Inventory | $43K+11.4% | $39K-43.4% | $68K-19.7% | $85K-17.1% | $103K+92.7% | $53K-47.1% | $101K+76.8% | $57K-9.0% | $63K+47.6% | $42K | N/A |
| Accounts Receivable | $69K-37.6% | $111K+137.5% | $47K-76.6% | $199K+130.5% | $86K-56.9% | $201K+146.8% | $81K+337.2% | $19K+57.5% | $12K | N/A | N/A |
| Goodwill | $3.0M0.0% | $3.0M0.0% | $3.0M0.0% | $3.0M0.0% | $3.0M0.0% | $3.0M-5.1% | $3.2M | N/A | N/A | N/A | N/A |
| Total Liabilities | $5.4M-1.7% | $5.4M-23.0% | $7.1M-63.6% | $19.4M+139.8% | $8.1M+64.4% | $4.9M-15.3% | $5.8M+120.1% | $2.6M+25.8% | $2.1M+70.5% | $1.2M | N/A |
| Current Liabilities | $5.1M-3.2% | $5.3M-18.9% | $6.6M-62.0% | $17.3M+168.8% | $6.4M+200.3% | $2.1M-31.5% | $3.1M+111.0% | $1.5M+35.0% | $1.1M+213.2% | $350K | N/A |
| Total Equity | -$905K+35.7% | -$1.4M-38.6% | -$1.0M+92.1% | -$12.9M-1194.6% | -$994K-136.8% | $2.7M-3.6% | $2.8M+247.2% | -$1.9M-15.0% | -$1.7M-775.1% | -$189K-206.6% | -$62K |
| Retained Earnings | -$42.7M-5.1% | -$40.6M-12.5% | -$36.1M-7.5% | -$33.6M-59.7% | -$21.0M-23.2% | -$17.1M-13.1% | -$15.1M-23.2% | -$12.2M-15.3% | -$10.6M-20.1% | -$8.8M | N/A |
Not reported in any period shown, so not listed: Long-Term Debt.
PVNNF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.2M+23.5% | -$2.9M-238.6% | -$853K-7.5% | -$794K+59.9% | -$2.0M+23.6% | -$2.6M-19.5% | -$2.2M-69.4% | -$1.3M-15.8% | -$1.1M+33.8% | -$1.7M-50.6% | -$1.1M |
| Capital Expenditures | $16K-82.9% | $93K+4884.9% | $2K-34.7% | $3K-76.0% | $12K-34.7% | $18K+734.6% | $2K-84.2% | $14K-67.1% | $42K-27.3% | $58K+36.4% | $42K |
| Free Cash Flow | -$2.2M+25.3% | -$3.0M-248.7% | -$855K-7.4% | -$797K+60.0% | -$2.0M+23.7% | -$2.6M-20.2% | -$2.2M-67.7% | -$1.3M-12.8% | -$1.1M+33.6% | -$1.7M-50.1% | -$1.2M |
| Investing Cash Flow | -$16K+82.9% | -$93K-4884.9% | -$2K-100.2% | $809K+6894.2% | -$12K+34.7% | -$18K-238.2% | $13K+195.2% | -$14K+67.1% | -$42K+27.3% | -$58K-399.3% | $19K |
| Financing Cash Flow | $2.5M-24.6% | $3.3M+291.6% | $849K+2587.9% | -$34K-101.8% | $1.9M-18.3% | $2.3M-7.7% | $2.5M+77.0% | $1.4M+194.7% | $479K-79.2% | $2.3M+97.5% | $1.2M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
PVNNF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.7%-7.0pp | 37.7%-14.5pp | 52.2%+48.9pp | 3.3%-47.3pp | 50.6%+34.8pp | 15.7%+64.5pp | -48.8%-48.1pp | -0.7%+0.4pp | -1.1%+35.9pp | -36.9%-11.7pp | -25.2% |
| Operating Margin | -405.9% | -835.0% | -451.9% | 358.5% | 608.3% | 690.9% | 3278.4% | -1973.3% | -2597.2% | -3332.4% | -4426.3% |
| Net Margin | -432.9% | -747.4% | -442.9% | 1647.6% | 826.1% | 428.1% | 3206.5% | -2076.6% | -2595.6% | -6925.4% | -5417.4% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | 73.0%-28.5pp | 101.5% | N/A | N/A | N/A | N/A |
| Return on Assets | -46.6%+65.2pp | -111.8%-70.1pp | -41.6%-233.4pp | 191.7%+136.1pp | 55.7%+29.8pp | 25.9%-7.2pp | 33.0%+253.1pp | -220.1%+178.9pp | -399.0%-14.7pp | -384.3% | N/A |
| Current Ratio | 0.21+0.1x | 0.14+0.1x | 0.060.0x | 0.020.0x | 0.07-0.2x | 0.220.0x | 0.230.0x | 0.230.0x | 0.21-2.1x | 2.33 | N/A |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | 1.82-0.3x | 2.07 | N/A | N/A | N/A | N/A |
| FCF Margin | -465.3% | -494.3% | -150.4% | -104.6% | -416.1% | -566.5% | -2449.0% | -1658.7% | -1680.8% | -2988.0% | -3921.5% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$905K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.21), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Pv Nano Cell Ranks
Frequently Asked Questions
What is Pv Nano Cell's annual revenue?
Pv Nano Cell (PVNNF) reported $479K in total revenue for fiscal year 2023. This represents a -20.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Pv Nano Cell's revenue growing?
Pv Nano Cell (PVNNF) revenue declined by 20.7% year-over-year, from $603K to $479K in fiscal year 2023.
Is Pv Nano Cell profitable?
No, Pv Nano Cell (PVNNF) reported a net income of -$2.1M in fiscal year 2023.
What is Pv Nano Cell's EBITDA?
Pv Nano Cell (PVNNF) had EBITDA of -$1.9M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.
What is Pv Nano Cell's gross margin?
Pv Nano Cell (PVNNF) had a gross margin of 30.7% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.
What is Pv Nano Cell's free cash flow?
Pv Nano Cell (PVNNF) recorded an outflow of $2.2M in free cash flow during fiscal year 2023. This represents a 25.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Pv Nano Cell's operating cash flow?
Pv Nano Cell (PVNNF) recorded an outflow of $2.2M in operating cash flow during fiscal year 2023, representing cash used by core business activities.
What are Pv Nano Cell's total assets?
Pv Nano Cell (PVNNF) had $4.4M in total assets as of fiscal year 2023, including both current and long-term assets.
What are Pv Nano Cell's capital expenditures?
Pv Nano Cell (PVNNF) invested $16K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.
How much does Pv Nano Cell spend on research and development?
Pv Nano Cell (PVNNF) invested $280K in research and development during fiscal year 2023.
What is Pv Nano Cell's current ratio?
Pv Nano Cell (PVNNF) had a current ratio of 0.21 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.
What is Pv Nano Cell's return on assets (ROA)?
Pv Nano Cell (PVNNF) had a return on assets of -46.6% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.
What is Pv Nano Cell's cash runway?
Based on fiscal year 2023 data, Pv Nano Cell (PVNNF) had $647K in cash against an annual operating cash burn of $2.2M. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Pv Nano Cell's debt-to-equity ratio negative or not reported?
Pv Nano Cell (PVNNF) has negative shareholder equity of -$905K as of fiscal year 2023, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Pv Nano Cell's Altman Z-Score?
Pv Nano Cell (PVNNF) has an Altman Z-Score of -15.86, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Pv Nano Cell's Piotroski F-Score?
Pv Nano Cell (PVNNF) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Pv Nano Cell's earnings high quality?
Pv Nano Cell (PVNNF) reported a net loss of $2.1M while operations used $2.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.